|Table of Contents|

Epidemiological characteristics of malignant tumors in the Fourth Division of the Xinjiang Production and Construction Corps from 2016 to 2020

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 02
Page:
334-337
Research Field:
Publishing date:

Info

Title:
Epidemiological characteristics of malignant tumors in the Fourth Division of the Xinjiang Production and Construction Corps from 2016 to 2020
Author(s):
ZHAO Min1; CHENG Jian1; WANG Shujun2
1.Hematology and Oncology Department；2.Medical Record Department,the Hospital of the Fourth Division of the Xinjiang Production and Construction Corps，Xinjiang Yining 835000，China.
Keywords:
malignant tumor; incidence; epidemiology; corps
PACS:
R73-31
DOI:
10.3969/j.issn.1672-4992.2024.02.024
Abstract:
Objective:To understand the epidemic characteristics of malignant tumors in the Fourth Division of the Xinjiang Production and Construction Corps from 2016 to 2020,and provide scientific basis for the prevention and control strategies of malignant tumors.Methods：Collect the medical records of patients with malignant tumors in Xinjiang Fourth Division from 2016 to 2020,analyze the clinical data of patients' gender,age and pathological types,and calculate the incidence of malignant tumors in the fourth division,China standard incidence and other indicators.Results：From 2016 to 2020,there were 2 612 new malignant tumor patients in the medical and health institutions at all levels of the Fourth Division,with an average annual crude incidence rate of 244.0/105,and the China standard incidence rate of 209.5/105,showing an upward trend.The overall incidence rate of women was higher than that of men（246.4/105 vs 241.7/105）,and that of Han nationality was higher than that of ethnic minorities.There were two peaks in the onset age of the whole population,which are 50 years old and 77 years old respectively.The top 10 malignant tumors are malignant tumors of trachea/bronchus/lung,colorectal cancer,breast cancer,cervical cancer,prostate cancer,stomach cancer,primary liver cancer,endometrium cancer,esophageal cancer and thyroid cancer,accounted for about 73.4% of all cases.Among the units under the jurisdiction of the Fourth Division,the top four units were 69 regiments,72 regiments,73 regiments and 77 regiments,with the average annual incidence rates of 332.4/105,326.4/105,307.5/105 and 302.7/105 respectively.Conclusion：The incidence of malignant tumors in the Fourth Division is close to the national level,and the epidemic characteristics of each jurisdiction are different.Comprehensive prevention and control measures such as early diagnosis and treatment should be carried out according to different genders,ages and jurisdictions.

References:

［1］ Global Burden of Disease 2019 Cancer Collaboration.Cancer incidence,mortality,years of life lost,years lived with disability,and disability-adjusted life years for 29 cancer groups from 2010 to 2019:a systematic analysis for the global burden of disease study 2019［J］.JAMA Oncol,2022,8(3):420-444.
［2］ 高蓓,初海超,芦文丽,等.1990-2019年中国恶性肿瘤疾病负担变化趋势分析［J］.中华疾病控制杂志,2022,26(4):430-436,489. GAO P,CHU HC,LU WL,et al.Changing trend concerning the burden of cancer between 1990 and 2019 in China［J］.Chinese Journal of Disease Control & Prevention,2022,26(4):430-436,489.
［3］ 孙可欣,郑荣寿,张思维,等.2015年中国恶性肿瘤流行情况分析［J］.中华肿瘤杂志,2019,41(1):19-28. SUN KX,ZHENG RS,ZHANG SW,et al.Report of cancer epidemiology in China,2015［J］.Chinese Journal of Oncology,2019,41(1):19-28.
［4］ 龚政,申嘉丛,敬雯,等.2016年新疆生产建设兵团恶性肿瘤疾病负担研究［J］.中华肿瘤防治杂志,2018,25(22):1541-1546. GONG Z,SHEN JC,JING W,et al.Burden of disease due to malignant neoplasms in Xinjiang Production and Construction Crops in 2016［J］.Chinese Journal of Cancer Prevention and Treatment,2018,25(22):1541-1546.
［5］ 吴春晓,顾凯,庞怡,等.2016年上海市恶性肿瘤发病和死亡情况与2002-2016年的变化趋势分析［J］.中国癌症杂志,2021,31(10):879-891. WU CX,GU K,PANG Y,et al.Analysis of the current status of cancer incidence and mortality in Shanghai,2016 and trends of 2002-2016 ［J］.China Oncology,2021,31(10):879-891.
［6］ 李灿,王静,廖先珍,等.2014年-2018年湖南省肿瘤登记地区恶性肿瘤发病与死亡特征及变化趋势分析［J］.肿瘤药学,2022,12(04):528-535. LI C,WANG J,LIAO XZ,et al.Analysis on the characteristics and trend of cancer incidence and mortality in the registered regions of Hunan Province from 2014 to 2018 ［J］.Anti-tumor Pharmacy,2022,12(04):528-535.
［7］ 陈宏达,郑荣寿,王乐,等.2019年中国肿瘤流行病学研究进展［J］.中华疾病控制杂志,2020,24(04):373-379. CHEN HD,ZHENG RS,WANG L,et al.Progress in cancer epidemiology research in China in 2019 ［J］.Chinese Journal of Disease Control & Prevention,2020,24(04):373-379.
［8］ 唐慧,郭鸿,曹芳,等.2005-2015年中国0～14岁儿童恶性肿瘤流行特征研究［J］.中国全科医学,2022,25(08):984-989,1006. TANG H,GUO H,CAO F,et al.Characteristics of cancer epidemiology among 0~14 years old Chinese children,2005-2015［J］.Chinese General Practice,2022,25(08):984-989,1006.
［9］ 杨允亚,黄军,刘颖,等.2001-2020年贵州省黔南州儿童恶性肿瘤发病特征及趋势变化［J］.现代预防医学,2021,48(17):3130-3134. YANG YY,HUANG J,LIU Y,et al.Incidence trends and characteristics of children malignant tumors in Qiannan area of Guizhou,2001-2020 ［J］.Modern Preventive Medicine,2021,48(17):3130-3134.
［10］ 刘杰,朱丽萍,徐艳,等.江西省肿瘤登记地区白血病流行状况分析［J］.中国卫生统计,2019,36(03):400-402,406. LIU J,ZHU LP,XU Y,et al.Epidemiological analysis of leukemia in tumor registration areas of Jiangxi Province ［J］.Chinese Journal of Health Statistics,2019,36(03):400-402,406.
［11］ 阿依姆妮萨·阿卜杜热合曼,姑丽斯坦·阿不都热西提,阿斯亚·麦麦吐逊,等.维吾尔族成人急性髓系白血病(非急性早幼粒细胞白血病)骨髓肾母细胞瘤基因1和转录因子ETS-1表达与预后的关系［J］.安徽医药,2023,27(3):466-470. Ayimunisa-Abudureheman,Gulisitan-Abudourexiti,Asiya-Maymaytituxun,et al.Relationship between WT1 and transcription factor ETS-1 expression and prognosis in Uygur adult patients with acute myeloid leukemia (non acute promyelocytic leukemia) ［J］.Anhui Medical and Pharmaceutical Journal,2023,27(3):466-470.
［12］ 董辉,汤质如,严训,等.安徽省恶性肿瘤治疗费用分析-基于“卫生费用核算体系2011”［J］.卫生经济研究,2021,38(02):58-61,66. DONG H,TANG ZR,YAN X,et al .Analysis on malignant tumor treatment cost in Anhui province-based on the SHA 2011［J］.Health Economics Research,2021,38(02):58-61,66.
［13］ 李辉章,杜灵彬,朱陈,等.2000-2015年浙江省肿瘤登记地区恶性肿瘤发病年龄变化特征分析［J］.中华预防医学杂志,2019,53(12):1253-1258. LI ZH,DU LB,ZHU C,et al.Analysis on the age of onset of malignant tumors in cancer registration areas in Zhejiang Province from 2000 to 2015［J］.Chinese Journal of Preventive Medicine,2019,53(12):1253-1258.
［14］ LEI SY,ZHENG RS,ZHANG SW,et al.Global patterns of breast cancer incidence and mortality:A population-based cancer registry data analysis from 2000 to 2020 ［J］.Cancer Communications,2021,41(11):1183-1194.
［15］ 丁贤彬,吕晓燕,焦艳,等.2006-2021年重庆市女性宫颈癌发病率长期趋势分析［J］.现代肿瘤医学,2023,31(12):2323-2329. DING XB,LV XY,JIAO Y,et al.Long trend of cervical cancer incidence among female residents between 2006 and 2021 in Chongqing,China ［J］.Modern Oncology,2023,31(12):2323-2329.
［16］ 马思琦,宋婉婷,李一帆,等.山东省上消化道癌危险因素的病例对照研究［J］.中华肿瘤防治杂志,2022,29(19):1378-1382. MA SQ,SONG WT,LI YF,et al.Risk factors of upper gastrointestinal cancer in Shandong Province:a case-control study ［J］.Chinese Journal of Cancer Prevention and Treatment,2022,29(19):1378-1382.
［17］ 李志学,刘峥,马艳,等.1990-2019年中国人群癌症归因于超重肥胖的疾病负担分析与模型预测［J］.现代肿瘤医学,2023,31(12):2314-2322. LI ZX,LIU Z,MA Y,et al.Cancer burden attributable to excess body weight in China:Trend analysis from 1990 to 2019 and future predictions ［J］.Modern Oncology,2023,31(12):2314-2322.

Memo

Memo:
第四师可克达拉市科技计划项目（编号：2022SF10）
Last Update: 1900-01-01